Livongo Health company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Acq - P2P | Acquired

Total Raised




About Livongo Health

Livongo Health (NASDAQ: LVGO) offers a mobile monitoring platform that empowers people with chronic conditions such as diabetes, hypertension, weight management, diabetes prevention, and behavioral health issues to take action when it is most likely to have clinical benefits. Its team of data scientists aggregates and interprets substantial amounts of health data and information to create personalized and timely health signals for users.

Livongo Health Headquarter Location

150 W. Evelyn Ave Suite 150

Mountain View, California, 94041,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Livongo Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Livongo Health is included in 10 Expert Collections, including Digital Health.


Digital Health

13,495 items

Companies developing and enabling evidence-based, software-driven therapeutic interventions to prevent, manage, or treat a medical disorder or disease. (*Scope follows the Digital Therapeutics Alliance definition)


Mental Health Tech

1,223 items

This collection includes companies applying technology to problems of emotional, psychological, and social well-being. Examples include companies working in areas such as substance abuse, eating disorders, stress reduction, depression, PTSD, and anxiety.


Conference Exhibitors

5,501 items

HLTH is a healthcare event bringing together startups and large companies from pharma, health insurance, business intelligence, and more to discuss the shifting landscape of healthcare


Tech IPO Pipeline

286 items


Medical Devices

11,530 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.



1,750 items

Livongo Health Patents

Livongo Health has filed 24 patents.

The 3 most popular patent topics include:

  • Diabetes
  • Insulin therapies
  • Blood pressure
patents chart

Application Date

Grant Date


Related Topics




Diabetes, Insulin therapies, Audio engineering, Blood tests, Audio codecs


Application Date


Grant Date



Related Topics

Diabetes, Insulin therapies, Audio engineering, Blood tests, Audio codecs



Latest Livongo Health News

Bodyport Announces Appointment of Jim Pursley to Board of Directors

Jun 23, 2022

Seasoned healthcare executive added as Bodyport commercial efforts ramp up June 23, 2022 08:00 AM Eastern Daylight Time SAN FRANCISCO--( BUSINESS WIRE )-- Bodyport , a biomarker-guided digital therapeutics company on a mission to address complex chronic conditions, announced today the appointment of Jim Pursley to the company’s board of directors. “I am excited to join the Bodyport Board of Directors as they reimagine care for patients living with complex chronic conditions. Bodyport’s focus on the patient has driven them to create an incredibly simple solution for patients with congestive heart failure. The Bodyport solution will reduce common monitoring complexities for patients while advancing how clinicians manage their patients,” Pursley said. “Bodyport is uniquely positioned to transform and improve the quality of life for millions of people around the globe. I am proud to support the company’s mission.” Pursley is the President of Hinge Health and most recently served as Chief Commercial Officer for Livongo Health, where he was part of the founding executive team that built and grew Livongo into a global leader in consumer focused chronic condition management. He helped take them public in 2019, ultimately culminating in an $18.5 billion acquisition by Teladoc Health. Prior to Livongo, Pursley held executive leadership roles at Intel-GE Care Innovations and GE Healthcare. He earned his bachelor’s degree in Management Science & Information Systems from the Pennsylvania State University and an MBA from Northwestern University’s Kellogg School of Management. Additionally, Pursley is a Heart of Chicago Board member for the American Heart Association. “Jim is an extremely valued addition as a proven leader in transforming how chronic conditions are managed. We are pleased to have Jim on the board as we move into commercialization and growth of our solution,” said John Lipman, CEO of Bodyport. Pursley joins current board members and Bodyport Co-Founders Corey Centen and Sarah Smith; Bodyport CEO John Lipman; Garry Tan, Managing Partner at Initialized Capital; Stefan Pflanz, Executive Director at Boehringer Ingelheim Venture Fund; and Chair Phyllis Whiteley, PhD, of Playground Global. About Bodyport Bodyport is a biomarker-guided digital therapeutics company on a mission to address complex chronic conditions by embedding a sophisticated biomarker platform into simple, easy-to-use devices. Bodyport captures hemodynamic signals through the Cardiac Scale to power optimized interventions tailored to the patient. By not requiring a wearable device or surgical implant, the solution seamlessly integrates into a patient’s daily life. Bodyport is focused on keeping patients with cardiorenal conditions healthier and out of the hospital. The company is tackling heart failure first to noninvasively assess heart function and fluid status in a single step at home. Bodyport is HIPAA compliant and has received SOC2 Type 2 certification. Based in San Francisco, the company is backed by top-tier investors such as Boehringer Ingelheim Venture Fund, Playground Global, Initialized Capital, Y Combinator, and Rock Health. For more information, visit and follow the company on LinkedIn and Twitter . Contacts

  • When was Livongo Health founded?

    Livongo Health was founded in 2014.

  • Where is Livongo Health's headquarters?

    Livongo Health's headquarters is located at 150 W. Evelyn Ave, Mountain View.

  • What is Livongo Health's latest funding round?

    Livongo Health's latest funding round is Acq - P2P.

  • How much did Livongo Health raise?

    Livongo Health raised a total of $232M.

  • Who are the investors of Livongo Health?

    Investors of Livongo Health include Teladoc Health, General Catalyst, Kleiner Perkins Caufield & Byers, Sapphire Ventures, 7wire Ventures and 13 more.

  • Who are Livongo Health's competitors?

    Competitors of Livongo Health include Zhiyun Health, PeerWell, Hello Heart, BeatO, DIABNEXT, WellView Health, Juli, Omada Health, Cecelia Health, Dnurse and 41 more.

You May Also Like

Omada Health Logo
Omada Health

Omada Health is a digital behavioral medicine company that helps people to change the habits that put them most at risk for serious but largely preventable chronic conditions like heart disease and type 2 diabetes. The company brings behavioral counseling to anyone with an Internet connection, using insights about social networking, gaming, and behavioral science to motivate changes in lifestyle and deliver clinically-meaningful results.

Glooko Logo

Glooko's universal diabetes software products provide insights to improve outcomes for people with diabetes and their care teams. Glooko's systems synchronize data from more than 190 diabetes devices and activity trackers, and they deliver integrated, timely and useful patient data, including glucose levels, blood pressure, weight, and food, insulin and medication intake.

One Drop Logo
One Drop

One Drop is a consumer digital health company that has developed One Drop. Available for download for iOS and Apple Watch, One Drop harnesses the power of mobile computing and data science to empower people with diabetes to live healthier lives.

WellDoc Logo

WellDoc is a healthcare behavioral science and technology company that focuses on simplifying the way chronic diseases are managed through a collaborative approach that breaks down the barriers of engagement and adherence by providing patients and healthcare providers with real-time information. WellDoc has developed a technology-based solution designed to help people with chronic diseases better manage conditions. The flagship product, DiabetesManager, provides a system for patients and health care providers to coordinate diabetes care, propel self-management and achieve long-term adherence.

Emperra Logo

Emperra is a startup that creates a digital diabetes management solution. The company's Esysta technology allows the complete capture of all relevant data such as insulin doses, blood sugar levels and carbohydrates.

InSpark Technologies Logo
InSpark Technologies

Our software provides impactful diabetes management insights at the right time; when people test their blood sugar levels. We can present feedback on undesirable patterns occuring in upcoming problem areas of the day, patterns of glucose variability, risk of hypoglycemia, estimated HbA1c, and insulin sensitivity on monitoring devices or on connected mobile phones.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.